GlassScriptPhysician profile
Michelle S Schecter
NPI 1508204165
$1,817.98
in general payments reported to CMS, 2019-2025
9 companies · $912 in 2025
The $912 reported for 2025 was more than what 79% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $163 · 2022: $125 · 2023: $375 · 2024: $243 · 2025: $912.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,530.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $743.42 | 2023-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $388.05 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $250.00 | 2022-2023 | Farxiga |
| Medtronic, INC. | $158.61 | 2025 | Linq II, Symplicity G3, Micra |
| E.R. Squibb & Sons, L.L.C. | $149.21 | 2025 | Camzyos |
| Biotronik INC. | $41.05 | 2025 | Amvia Edge |
| Abbvie INC. | $37.83 | 2021 | |
| Csl Behring | $28.93 | 2025 | Kcentra |
| Pfizer INC. | $20.88 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Schecter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.